Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hawkins

Showing results (451-460 of 479) with videos related to

Pageof 48
Sort By:
Nature Communications|January 22, 2016
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profileSophie Valleix, Guglielmo Verona, Noémie Jourde-Chiche, et al.
Circulation|November 3, 2022
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 YearsAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
Nature|April 28, 2006
Targeting C-reactive protein for the treatment of cardiovascular diseaseMark B Pepys, Gideon M Hirschfield, Glenys A Tennent, et al.
European Heart Journal|October 14, 2022
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatmentAna Martinez-Naharro, Rishi Patel, Tushar Kotecha, et al.
Heart (British Cardiac Society)|September 9, 2021
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosisKush P Patel, Paul Richard Scully, Christian Nitsche, et al.
Journal of the American College of Cardiology|March 26, 2024
Stratifying Disease Progression in Patients With Cardiac ATTR AmyloidosisAdam Ioannou, Francesco Cappelli, Michele Emdin, et al.
Circulation|May 22, 2019
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin AmyloidosisThirusha Lane, Marianna Fontana, Ana Martinez-Naharro, et al.
Circulation. Cardiovascular Imaging|April 20, 2021
Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic AmyloidLiza Chacko, Michele Boldrini, Raffaele Martone, et al.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Haematologica|June 26, 2025
Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosisMuhammad Umaid Rauf, Steven Law, Marisa Santostefano, et al.
Pageof 48

Showing results (451-460 of 479) with videos related to

Sort By:
Pageof 48
Nature Communications|January 22, 2016
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profileSophie Valleix, Guglielmo Verona, Noémie Jourde-Chiche, et al.
Circulation|November 3, 2022
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 YearsAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
Nature|April 28, 2006
Targeting C-reactive protein for the treatment of cardiovascular diseaseMark B Pepys, Gideon M Hirschfield, Glenys A Tennent, et al.
European Heart Journal|October 14, 2022
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatmentAna Martinez-Naharro, Rishi Patel, Tushar Kotecha, et al.
Heart (British Cardiac Society)|September 9, 2021
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosisKush P Patel, Paul Richard Scully, Christian Nitsche, et al.
Journal of the American College of Cardiology|March 26, 2024
Stratifying Disease Progression in Patients With Cardiac ATTR AmyloidosisAdam Ioannou, Francesco Cappelli, Michele Emdin, et al.
Circulation|May 22, 2019
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin AmyloidosisThirusha Lane, Marianna Fontana, Ana Martinez-Naharro, et al.
Circulation. Cardiovascular Imaging|April 20, 2021
Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic AmyloidLiza Chacko, Michele Boldrini, Raffaele Martone, et al.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Haematologica|June 26, 2025
Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosisMuhammad Umaid Rauf, Steven Law, Marisa Santostefano, et al.
Pageof 48